Krónikus mieloid leukémia (CML): vizsgálatok itt: Hollandia
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Utrecht
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 1/2. fázisTaking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Utrecht
- Életkor
- 1 év to 17 év
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 2. fázisTaking peopleStudy to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
- Where
- Utrecht
- Életkor
- Up to 17 év
- People
- 16 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522138-29-00 · EU 2025-522138-29-00 - 1/2. fázisNot yet taking people in HollandiaA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Amsterdam, Groningen, Maastricht, Nijmegen
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - 1/2. fázisTaking peopleStudy to Evaluate the Safety and Tolerability of EP0042
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00 - 1. fázisTaking peopleA Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00 - 2. fázisTaking peopleA multicenter trial where patients with CML stop medication a second time.
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Region Uppsala
See details and how to join2024-515409-25-00 · EU 2024-515409-25-00 - No phaseTaking peopleInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- Utrecht
- Életkor
- Up to 18 év
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735